Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002096014-25-000004
Filing Date
2025-11-24
Accepted
2025-11-24 19:05:07
Documents
1
Period of Report
2025-11-21

Document Format Files

Seq Description Document Type Size
1 form4-11242025_071103.html 4  
1 form4-11242025_071103.xml 4 6369
  Complete submission text file 0002096014-25-000004.txt   7869
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Issuer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O DBV TECHNOLOGIES S.A. 107 AVENUE DE LA REPUBLIQUE CHATILLON France 92320
Business Address
Trapp Kevin Michael (Reporting) CIK: 0002096014 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36697 | Film No.: 251514657